Hypertension in Pregnancy is converting to Open Access
Hypertension in Pregnancy is an international journal in the English language which publishes top-level research from all areas of hypertension during gestation. Contributions concerning physiology of circulatory control in pregnancy, pathophysiology of hypertensive disorders of pregnancy including mechanistic studies based on animal models, methodology, therapy, or any other material relevant to the relationship between elevated blood pressure and pregnancy are acceptable. Published material includes original articles, clinical trials, solicited and unsolicited reviews, editorials, letters, and other material deemed pertinent by the editors.
Hypertension in Pregnancy is the journal with the longest record of PubMed presence with this thematic focus. In the next bold move, and under the leadership of its editor, Dr. Garovic, the journal will convert to an Open Access publishing model that will be advantageous to authors, readership, and patients in several ways. First, it will ensure that the research published in Hypertension in Pregnancy will be disseminated internationally with no barriers to access. Second, it will strengthen our commitment to researchers in the field by ensuring that their research accomplishments will reach the widest possible audience. Third, global dissemination of emerging scientific evidence may help in resolving socioeconomic and racial health care disparities in women’s health during pregnancy and throughout women’s reproductive lives. Fourth, the market-leading web platform provided by Taylor & Francis and a dedicated Hypertension in Pregnancy communications account, will ensure the widest possible audience and global visibility.
As part of the journal’s transition, all manuscripts received after 29th June 2022 will proceed through Hypertension in Pregnancy’s Open Access submission portal. Authors who submit after this date will, if their article is accepted, be required to pay an article publishing charge (APC) which can be covered by an author’s funder or institution.
We look forward to receiving your submissions and hope you join us to embrace Hypertension in Pregnancy’s Open Access future.
Dr. Vesna Garovic is Professor of Medicine, Division of Nephrology and Hypertension, Mayo Clinic Rochester, Minnesota, and holds joint appointment in Obstetrics & Gynecology. She currently serves as Chair of Division of Nephrology and Hypertension, Vice-Chair for Research, Department of Internal Medicine, and as Director, Clinical Resaearch and Trials Unit, Mayo Clinic Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN.
She has been NIH-funded over the course of 15 years, she serves as a chartered member of the NIH Pregnancy/Neonatology study section (2020-2024), and has published over 190 peer-reviewed papers. Her clinical and research interests in hypertensive pregnancy disorders and preeclampsia span several research areas: diagnosis and treatment of hypertension in pregnancy, underlying molecular mechanisms, with the most recent focus on senescence, epigenetics, and epidemiology of long-term cardiovascular and renal effects, with the long-term objective of identifying diagnostic biomarkers and potential new therapeutic targets in order to improve immediate and long-term outcomes of this enigmatic disease.
Why publish open access?
Increase the visibility and readership of your research by publishing in a fully open access journal.
Make an impact beyond the academy by making your article accessible to anyone, anywhere (including readers in industry and even policy-makers).
Freely share your work with no restrictions or paywall.
Retain ownership of your research through our unrestrictive publishing agreements.
Discounts and waivers for researchers in developing countries are available. The journal will also consider requests for discretionary APC waivers. Find out if your institution or country has an open access agreement to publish with us.